Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Adamas Pharmaceuticals Inc (ADMS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A ARMISTICE CAPITAL, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2022 SC 13G/A Opaleye Management Inc. reports a 0% stake in Adamas Pharmaceuticals, Inc.
12/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/06/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/02/2021 EFFECT Form EFFECT - Notice of Effectiveness:
11/24/2021 4 BIGHAM MICHAEL (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 10,000 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 MAHONEY DAVID L (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 5,000 shares @ $0
Unknown transaction of 112,781 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 40,000 options to buy @ $6.08, valued at $243.2k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 75,000 shares @ $0
Unknown transaction of 600,000 shares @ $0
Disposed/sold 250,000 options to buy @ $6.25, valued at $1.6M
Disposed/sold 200,000 options to buy @ $1.99, valued at $398k
11/24/2021 4 Prentiss Christopher B (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 18,750 shares @ $0
Unknown transaction of 163,767 shares @ $0
Disposed/sold 37,500 options to buy @ $6.81, valued at $255.4k
Disposed/sold 50,000 options to buy @ $4.7, valued at $235k
11/24/2021 4 Ericson William W. (10% Owner) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 10,000 shares @ $0
Unknown transaction of 4,031,804 shares @ $0
Unknown transaction of 6,043 shares @ $0
Unknown transaction of 3,146 shares @ $0
Unknown transaction of 25,661 shares @ $0
Unknown transaction of 287,992 shares @ $0
Unknown transaction of 265,150 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 Shreedhar Vijay (Chief Commercial Officer) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Granted 18,750 shares @ $0
Unknown transaction of 186,786 shares @ $0
Disposed/sold 137,500 options to buy @ $4.67, valued at $642.1k
Disposed/sold 47,500 options to buy @ $2.32, valued at $110.2k
11/24/2021 4 Papapetropoulos Spyridon (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 20,975 shares @ $0
Disposed/sold 20,000 options to buy @ $4.35, valued at $87k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 RICHO ANNA (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 25,000 shares @ $0
Disposed/sold 20,000 options to buy @ $5.12, valued at $102.4k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 DEMSKI MARTHA J (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 16,000 shares @ $0
Unknown transaction of 5,000 shares @ $0
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 4 MacPhee John A (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc
Txns: Unknown transaction of 202,000 shares @ $0
Disposed/sold 24,000 options to buy @ $3.305, valued at $79.3k
Disposed/sold 10,000 options to buy @ $4.8, valued at $48k
Disposed/sold 10,000 options to buy @ $2.7, valued at $27k
Disposed/sold 10,000 options to buy @ $5.21, valued at $52.1k
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
11/24/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/24/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/24/2021 8-K Resignation/termination of a director
Docs: "TENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAMAS PHARMACEUTICALS, INC.",
"AMENDED & RESTATED BYLAWS OF ADAMAS PHARMACEUTICALS, INC."
11/24/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/23/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/23/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/18/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/10/2021 10-Q Quarterly Report for the period ended September 30, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy